Related references
Note: Only part of the references are listed.Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
J. Hirvonen et al.
MOLECULAR PSYCHIATRY (2012)
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
Murat Yuecel et al.
SCHIZOPHRENIA BULLETIN (2012)
Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function
Meredith J. Noetzel et al.
MOLECULAR PHARMACOLOGY (2012)
Adolescent cannabinoid exposure attenuates adult female sexual motivation but does not alter adulthood CB1R expression or estrous cyclicity
Benjamin Chadwick et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Learning and Generalization in Schizophrenia: Effects of Disease and Antipsychotic Drug Treatment
Daphna Shohamy et al.
BIOLOGICAL PSYCHIATRY (2010)
Role of Cannabinoid Receptor Type 1 Desensitization in Greater Tetrahydrocannabinol Impairment of Memory in Adolescent Rats
Nicole L. T. Moore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Object recognition memory and the rodent hippocampus
Nicola J. Broadbent et al.
LEARNING & MEMORY (2010)
Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
Stephen M. Eggan et al.
NEUROPSYCHOPHARMACOLOGY (2010)
RELATIONSHIP OF CANNABINOID CB1 RECEPTOR AND CHOLECYSTOKININ IMMUNOREACTIVITY IN MONKEY DORSOLATERAL PREFRONTAL CORTEX
S. M. Eggan et al.
NEUROSCIENCE (2010)
Cannabis use and cognitive functioning in first-episode schizophrenia patients
Jose Manuel Rodriguez-Sanchez et al.
SCHIZOPHRENIA RESEARCH (2010)
Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment
Nico Wegener et al.
BRAIN RESEARCH (2009)
Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation
Laura Gray et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
mGluR5 Has a Critical Role in Inhibitory Learning
Jian Xu et al.
JOURNAL OF NEUROSCIENCE (2009)
Hippocampal CB1 Receptors Mediate the Memory Impairing Effects of Δ9-Tetrahydrocannabinol
Laura E. Wise et al.
NEUROPSYCHOPHARMACOLOGY (2009)
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex
T. Rubino et al.
NEUROTOXICITY RESEARCH (2009)
The role of cannabis in cognitive functioning of patients with schizophrenia
Thomas Schnell et al.
PSYCHOPHARMACOLOGY (2009)
CNTRICS Final Task Selection: Long-Term Memory
John D. Ragland et al.
SCHIZOPHRENIA BULLETIN (2009)
Norbin Is an Endogenous Regulator of Metabotropic Glutamate Receptor 5 Signaling
Hong Wang et al.
SCIENCE (2009)
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects
M. Ellgren et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Signaling via CNS cannabinoid receptors
Ken Mackie
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour
T. Rubino et al.
NEUROPHARMACOLOGY (2008)
Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice
Ming-Huan Chan et al.
PSYCHOPHARMACOLOGY (2008)
Epigenetic mechanisms in drug addiction
William Renthal et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure
Heidi R. Quinn et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis
Amelie M. Achim et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression
D. Koethe et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa H. M. Moore et al.
LANCET (2007)
The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study
Louisa Degenhardt et al.
PSYCHOLOGICAL MEDICINE (2007)
Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls
Maria C. Jockers-Scheruebl et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats
Maria Ellgren et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood
M. Sabrina Spano et al.
BIOLOGICAL PSYCHIATRY (2007)
The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion
Miriam Schneider et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus
Yuki Hashimotodani et al.
JOURNAL OF NEUROSCIENCE (2007)
Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons
Elisa L. Hill et al.
JOURNAL OF NEUROPHYSIOLOGY (2007)
Fronto-hippocampal function during temporal context monitoring in schizophrenia
Anthony P. Weiss et al.
BIOLOGICAL PSYCHIATRY (2006)
Cannabinoids reveal importance of spike timing coordination in hippocampal function
David Robbe et al.
NATURE NEUROSCIENCE (2006)
Substance misuse and cognitive functioning in early psychosis: A 2 year follow-up
Amanda McCleery et al.
SCHIZOPHRENIA RESEARCH (2006)
Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar long-lasting deficits in object recognition and reduced social interaction in rats
Melanie O'Shea et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Neuronal cytoskeleton and synaptic densities are altered after a chronic treatment with the cannabinoid receptor agonist WIN 55,212-2
Patricia Tagliaferro et al.
BRAIN RESEARCH (2006)
Comorbid substance use and age at onset of schizophrenia
TRE Barnes et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases
M Arendt et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
CANTAB explicit memory is less impaired in addicted schizophrenia patients
S Potvin et al.
BRAIN AND COGNITION (2005)
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
JK Makara et al.
NATURE NEUROSCIENCE (2005)
Cannabis use and outcome of recent onset psychosis
A Grech et al.
EUROPEAN PSYCHIATRY (2005)
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction
A Caspi et al.
BIOLOGICAL PSYCHIATRY (2005)
Cortical inhibitory neurons and schizophrenia
DA Lewis et al.
NATURE REVIEWS NEUROSCIENCE (2005)
A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models
GG Kinney et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Correlates of substance abuse in adolescents with treatment-refractory schizophrenia and schizoaffective disorder
S Kumra et al.
SCHIZOPHRENIA RESEARCH (2005)
Endocannabinoid Metabolic Pathways and Enzymes
Alessia Ligresti et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
C Henquet et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia
K Zavitsanou et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol
AI Green et al.
SCHIZOPHRENIA RESEARCH (2004)
Regulation of histone acetylation during memory formation in the hippocampus
JM Levenson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Heritable differences in the dopaminergic regulation of sensorimotor gating - I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny
NR Swerdlow et al.
PSYCHOPHARMACOLOGY (2004)
Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats
M O'Shea et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus
J Kim et al.
NATURE NEUROSCIENCE (2004)
Functional interaction between NMDA and mGlu5 receptors: Effects on working memory, instrumental learning, motor behaviors, and dopamine release
H Homayoun et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Transitive inference in schizophrenia: impairments in relational memory organization
D Titone et al.
SCHIZOPHRENIA RESEARCH (2004)
Hippocampal activation during transitive inference in humans
S Heckers et al.
HIPPOCAMPUS (2004)
Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort
J Stirling et al.
SCHIZOPHRENIA RESEARCH (2003)
Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats
M Schneider et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Hippocampal dysfunction during episodic memory encoding in patients with schizophrenia - an fMRI study
DT Leube et al.
SCHIZOPHRENIA RESEARCH (2003)
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
L Arseneault et al.
BRITISH MEDICAL JOURNAL (2002)
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study
S Zammit et al.
BRITISH MEDICAL JOURNAL (2002)
Intracerebral microinjections of Δ9-tetrahydrocannabinol:: search for the impairment of spatial memory in the eight-arm radial maze in rats
N Egashira et al.
BRAIN RESEARCH (2002)
Cannabis use and psychosis: A longitudinal population-based study
J van Os et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia
S Heckers et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder
S Sevy et al.
ACTA PSYCHIATRICA SCANDINAVICA (2001)
Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
B Dean et al.
NEUROSCIENCE (2001)
Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2
J Lawston et al.
BRAIN RESEARCH (2000)
Cannabis, vulnerability, and the onset of schizophrenia:: an epidemiological perspective
M Hambrecht et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2000)
Gabaergic interneurons are the targets of cannabinoid actions in the human hippocampus
I Katona et al.
NEUROSCIENCE (2000)
Functional expression of cell surface cannabinoid CB1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons
AJ Irving et al.
NEUROSCIENCE (2000)
Share Paper
